Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Depreciation & Amortization (CF) (2023 - 2025)

Historic Depreciation & Amortization (CF) for Medical Group Holdings (SBC) over the last 3 years, with Q3 2025 value amounting to $746211.0.

  • Medical Group Holdings' Depreciation & Amortization (CF) fell 2672.42% to $746211.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 4577.65%. This contributed to the annual value of $3.8 million for FY2024, which is 6897.69% down from last year.
  • According to the latest figures from Q3 2025, Medical Group Holdings' Depreciation & Amortization (CF) is $746211.0, which was down 2672.42% from $636101.0 recorded in Q2 2025.
  • Medical Group Holdings' 5-year Depreciation & Amortization (CF) high stood at $2.6 million for Q4 2023, and its period low was $628304.0 during Q1 2025.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $931596.0 (2024), whereas its average is $1.1 million.
  • Per our database at Business Quant, Medical Group Holdings' Depreciation & Amortization (CF) plummeted by 6358.54% in 2024 and then crashed by 2344.85% in 2025.
  • Over the past 3 years, Medical Group Holdings' Depreciation & Amortization (CF) (Quarter) stood at $2.6 million in 2023, then crashed by 63.59% to $931596.0 in 2024, then decreased by 19.9% to $746211.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $746211.0 for Q3 2025, versus $636101.0 for Q2 2025 and $628304.0 for Q1 2025.